Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | ELF3 |
| Upstream (Parents) |
|---|
| (<<) ATP10B → ELF3 |
| (<<) GRHL2 → ELF3 |
| (<<) PRSS3 → ELF3 |
| (<<) CLDN3 → ELF3 |
| (<<) TUFT1 → ELF3 |
| Downstream (Children) |
|---|
| ELF3 → RHCG (>>) |
| ELF3 → ITGB6 (>>) |
| ELF3 → APOBEC1 (>>) |
| ELF3 → PLEKHA6 (>>) |
| ELF3 → CLDN3 (>>) |
| ELF3 → NR6A1 (>>) |
| ELF3 → SLC9A3 (>>) |
| ELF3 → KANK2 (>>) |
| ELF3 → CEACAM1 (>>) |
| ELF3 → LGALS4 (>>) |
| ELF3 → DSCR6 (>>) |
| ELF3 → SULT2B1 (>>) |
| ELF3 → PLEKHG6 (>>) |
